---
$id: https://graph.org.ai/products/commodity/51151606
$type: Product
source: UNSPSC
code: "51151606"
title: "Tropicamide"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tropicamide

**UNSPSC Code**: 51151606
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a diagnostic reagent and antimuscarinic agent with the molecular formula C17H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N0A3Z5XTC6, chemically known as hydracrylamide, n-ethyl-2-phenyl-n-(4-pyridylmethyl)- but generally known as tropicamide, which bears US NIH Compound Identifier 5593. European Medicines Agency schedules Tropicamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11342MIG. The term TROPICAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules tropicamide in its Anatomical Therapeutic Chemical (ATC) Classification. TROPICAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tropicamide under HS 29333999 and SITC 51574. As of Q4 2014, TROPICAMIDE remains the US FDA Preferred Term for this commodity. Tropicamide bears US NLM identifiers UMLS ID C0041190 and NCI Concept Code C47776. SMILES: O=C(N(CC1CCNCC1)CC)C(C1CCCCC1)CO.

